Synovics Pharmaceuticals, Inc. Announces the Settlement of all Legal Proceedings with Nostrum Pharmaceuticals., Dr. Nirmal Mulye and Anil Anand

PHOENIX--(BUSINESS WIRE)--Synovics Pharmaceuticals, Inc. (OTCBB:SYVC), a specialty pharmaceutical company, today announced that on July 31, 2007, the Company together with its subsidiary Synovics Laboratories, Inc. (“Synovics Labs”) settled its dispute with Nostrum Pharmaceuticals, Inc. (“Nostrum”), Nirmal Mulye, Ph.D. (“Mulye”) and Anil Anand.

Back to news